Koers Hua Medicine (Shanghai) Ltd. OTC Markets
Aandelen
HUMDF
KYG4644K1022
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,2028 USD | -54,93% | -.--% | -.--% |
Omzet 2023 | 76,61 mln. 10,6 mln. 9,84 mln. | Omzet 2024 * | - | Marktkapitalisatie | 1,38 mld. 190 mln. 177 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -211 mln. -29,21 mln. -27,11 mln. | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 | 22,9 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 |
-8,14
x | K/w-verhouding 2024 * |
-
| Werknemers | 177 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 86,36% |
Recentste transcriptie over Hua Medicine (Shanghai) Ltd.
1 dag | -54,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Chen
FOU | Founder | 61 | 10-11-09 |
Li Changhong
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Di Hong
COO | Chief Operating Officer | 45 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Nelsen
CHM | Chairman | 60 | 23-04-10 |
William Keller
BRD | Director/Board Member | 75 | - |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 01-09-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers 2552
- Koers HUMDF